These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4687453)
21. [Vaccination of children in 1999]. Levy J Rev Med Brux; 1999 Sep; 20(4):A317-20. PubMed ID: 10523915 [TBL] [Abstract][Full Text] [Related]
22. AAFP, AAP and ACIP release new childhood immunization schedule. Am Fam Physician; 1996 Jan; 53(1):395-6. PubMed ID: 8546057 [No Abstract] [Full Text] [Related]
23. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region]. Salvadori P Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974 [No Abstract] [Full Text] [Related]
24. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination. Lerman SJ; Bollinger M; Brunken JM Pediatrics; 1981 Jul; 68(1):18-22. PubMed ID: 7017582 [TBL] [Abstract][Full Text] [Related]
25. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E; Tischer A Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543 [TBL] [Abstract][Full Text] [Related]
26. Vaccination coverage of 2-year-old children--United States, 1992-1993. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(15):282-3. PubMed ID: 8164635 [TBL] [Abstract][Full Text] [Related]
28. Recommendations for using MMR vaccine in children allergic to eggs. Khakoo GA; Lack G BMJ; 2000 Apr; 320(7239):929-32. PubMed ID: 10787255 [No Abstract] [Full Text] [Related]
29. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96]. Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798 [TBL] [Abstract][Full Text] [Related]
30. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
31. Simultaneous use of vaccines, indications, contraindications. Witte J Schweiz Rundsch Med Prax; 1975 Feb; 64(5):111-8. PubMed ID: 1236700 [No Abstract] [Full Text] [Related]
32. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella. Heath TC; Burgess MA; Forrest JM Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550 [No Abstract] [Full Text] [Related]
33. Measles, mumps, rubella vaccine and allergy to egg. Lang S Am Fam Physician; 1998 Sep; 58(4):863-4. PubMed ID: 9767722 [No Abstract] [Full Text] [Related]
34. [What is the present status of the common virus vaccines?]. Regnard J Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188 [No Abstract] [Full Text] [Related]
35. [Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance]. Ziemer B; Blank K; Hennig R Gesundheitswesen; 1998 May; 60(5):297-300. PubMed ID: 9676011 [TBL] [Abstract][Full Text] [Related]
36. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
37. Measles--United States, 1996, and the interruption of indigenous transmission. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):242-6. PubMed ID: 9082179 [TBL] [Abstract][Full Text] [Related]
38. [Is a second dose of the triple viral vaccine necessary?]. Echevarría JM; de Ory F Med Clin (Barc); 1997 Jun; 109(5):196-7. PubMed ID: 9289545 [No Abstract] [Full Text] [Related]